S&P/ASX All Ordinaries Index (ASX: XAO) shares rose by 7.55% last year and delivered total gross returns, including dividends, of 11.44%. The index closed the year at 8,420.5 points.
In comparison, the benchmark S&P/ASX 200 Index (ASX: XJO) lifted 7.49%, with total gross returns also coming in at 11.44%. The ASX 200 finished the year at 8,159.1 points.
Multiple ASX All Ords stocks delivered exceptional price growth in 2024. We provide a sample of these multi-bagger stocks below.
Here are 16 ASX shares that shot the lights out with a minimum doubling in stock price over the year.
ASX biotech share Mesoblast skyrocketed by 900% to close at $3.10 apiece on 31 December.
This ASX financial stock ripped in 2024 with the Zip share price soaring 352.5% to close at $2.96.
ASX tech share Appen catapulted 319.1% higher to close at $2.64 on 31 December.
This materials share soared 295.68% to finish the year at $5.50 per share.
The Nuix share price rocketed 232.63% higher in 2024 to close at $6.32 per share on 31 December.
Shares in ASX telecommunications company SuperLoop streaked 226.87% higher to $2.19.
Stock in social tracking app developer Life360 rose by 198.15% to finish the year at $22.54 per share.
The Spartan Resources share price rose by 171.15% in 2024. The ASX gold mining share closed the year at $1.41 apiece.
Fellow gold mining stock Ora Banda lifted 170.83% to close the year at 65 cents per share.
Shares in sports technology solutions provider Catapult lifted 169% to $3.71 over the 12 months.
ASX healthcare share Sigma leapt 162% higher to close at $2.62 on 31 December.
The Pro Medicus share price rose by 161% to finish 2024 at $250.12 per share.
The Telix Pharmaceuticals share price shot 144.14% higher to close at $24.61 on 31 December.
The Pinnacle Investment share price rose 126.69% to finish at $22.85 on 31 December.
This ASX biopharmaceutical share rocketed 120.6% to close out the year at $4.17.
TechnologyOne shares ascended 103.71% to close 2024 at $31.31 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.